Douglas A. Lauffenburger, PhD LinkedIn

Chair, Scientific Advisory Board

Science Advisory Board

Key Research

  • Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's disease
All publications

Interested in speaking with an expert?

We'll put you in touch with the right person on our team. 

Schedule Consultation